Conditions We Treat
Cellular Therapy Program
Our program is one of the few in the nation currently approved to administer CAR-T therapy for relapsed or refractory Acute Lymphoblastic Leukemia. Because we work with other specialties and departments, we can easily share skill sets and knowledge, ensuring the broadest care experience. Our program closely works with the Ottosen Family Blood and Marrow Transplant Program, which began in 2003 and consistently has greater than 90% one-year survival rate for allogenic transplants and is one of the best in the nation.
What is Cellular Therapy?
Cellular therapy is a type of treatment that uses living cells and the patient’s own immune system to fight cancer.
One type of Cellular Therapy is Chimeric Antigen Receptor T-cell (CAR-T) therapy. CAR-T therapy involves collecting T-cells from the blood and genetically modifying them so they recognize and destroy cancer cells. After genetic modification, the T-cells are returned to the patient to work against cancer cells. The CAR-T acts like a living drug. It’s a revolutionary and highly-effective treatment option, especially for patients who didn’t see results with traditional chemotherapy and/or radiation.